Literature DB >> 23034910

Cognitive impairment in lacunar strokes: the SPS3 trial.

Claudia Jacova1, Lesly A Pearce, Raymond Costello, Leslie A McClure, Stephen L Holliday, Robert G Hart, Oscar R Benavente.   

Abstract

OBJECTIVE: Lacunar strokes are a leading cause of cognitive impairment and vascular dementia. However, adequate characterization of cognitive impairment is lacking. The aim of this study was to estimate the prevalence and characterize the neuropsychological impairment in lacunar stroke patients.
METHODS: All English-speaking participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial (National Clinical Trial 00059306) underwent neuropsychological testing at baseline. Raw scores were converted to z scores using published norms. Those with impairment (z ≤ -1.5) in memory and/or nonmemory domains were classified as having mild cognitive impairment (MCI).
RESULTS: Among the 1,636 participants, average z scores on all tests were < 0, with the largest deficits seen on tests of episodic memory (range of means, -0.65 to -0.92), verbal fluency (mean, -0.89), and motor dexterity (mean, -2.5). Forty-seven percent were classified as having MCI (36% amnestic, 37% amnestic multidomain, 28% nonamnestic). Of those with modified Rankin score 0-1 and Barthel score = 100, 41% had MCI. Younger age (odds ratio [OR] per 10-year increase, 0.87), male sex (OR, 1.3), less education (OR, 0.13-0.66 for higher education levels compared to 0-4 years education), poststroke disability (OR, 1.4), and impaired activities of daily living (OR, 1.8) were independently associated with MCI.
INTERPRETATION: In this large, well-characterized cohort of lacunar stroke patients, MCI was present in nearly half, including many with minimal or no physical disabilities. Cognitive dysfunction in lacunar stroke patients may commonly be overlooked in clinical practice but may be as important as motor and sensory sequelae.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Year:  2012        PMID: 23034910      PMCID: PMC4198173          DOI: 10.1002/ana.23733

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  28 in total

1.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

2.  Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.

Authors:  Mark S Forman; Ian R Mackenzie; Nigel J Cairns; Eric Swanson; Philip J Boyer; David A Drachman; Bharati S Jhaveri; Jason H Karlawish; Alan Pestronk; Thomas W Smith; Pang-Hsien Tu; Giles D J Watts; William R Markesbery; Charles D Smith; Virginia E Kimonis
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

3.  Brief cognitive assessment for patients with cerebral small vessel disease.

Authors:  M O'Sullivan; R G Morris; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

4.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

Authors:  J E Graham; K Rockwood; B L Beattie; R Eastwood; S Gauthier; H Tuokko; I McDowell
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

5.  Sex differences in regional cerebral glucose metabolism during a resting state.

Authors:  R C Gur; L H Mozley; P D Mozley; S M Resnick; J S Karp; A Alavi; S E Arnold; R E Gur
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

Review 6.  Recent advances in the genetics of the ALS-FTLD complex.

Authors:  Huw R Morris; Adrian J Waite; Nigel M Williams; James W Neal; Derek J Blake
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

7.  Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.

Authors:  J S Snowden; S M Pickering-Brown; I R Mackenzie; A M T Richardson; A Varma; D Neary; D M A Mann
Journal:  Brain       Date:  2006-09-26       Impact factor: 13.501

8.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

9.  The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.

Authors:  Ian R A Mackenzie; Matt Baker; Stuart Pickering-Brown; Ging-Yuek R Hsiung; Caroline Lindholm; Emily Dwosh; Jennifer Gass; Ashley Cannon; Rosa Rademakers; Mike Hutton; Howard H Feldman
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

10.  An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.

Authors:  Rohan de Silva; Tammaryn Lashley; Catherine Strand; Anna-Maria Shiarli; Jing Shi; Jinzhou Tian; Kathryn L Bailey; Peter Davies; Eileen H Bigio; Kunimasa Arima; Eizo Iseki; Shigeo Murayama; Hans Kretzschmar; Manuela Neumann; Carol Lippa; Glenda Halliday; James MacKenzie; Rivka Ravid; Dennis Dickson; Zbigniew Wszolek; Takeshi Iwatsubo; Stuart M Pickering-Brown; Janice Holton; Andrew Lees; Tamas Revesz; David M A Mann
Journal:  Acta Neuropathol       Date:  2006-03-22       Impact factor: 17.088

View more
  35 in total

1.  Vascular Dementia.

Authors:  Alberto R Ramos; Salim I Dib; Clinton B Wright
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

2.  Long-term disability after lacunar stroke: secondary prevention of small subcortical strokes.

Authors:  Mandip S Dhamoon; Leslie A McClure; Carole L White; Kamakshi Lakshminarayan; Oscar R Benavente; Mitchell S V Elkind
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

3.  Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.

Authors:  Lesly A Pearce; Leslie A McClure; David C Anderson; Claudia Jacova; Mukul Sharma; Robert G Hart; Oscar R Benavente
Journal:  Lancet Neurol       Date:  2014-10-23       Impact factor: 44.182

4.  Cognitive performance following lacunar stroke in Spanish-speaking patients: results from the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Ana M Roldan; Antonio Arauz; Jorge Tapia; Raymond Costello; Leslie A McClure; Robert G Hart; Oscar R Benavente
Journal:  Int J Stroke       Date:  2015-06       Impact factor: 5.266

Review 5.  Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain.

Authors:  Young-Kook Kim; Juhyun Song
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

6.  Vascular contributions to cognitive impairment.

Authors:  Clinton B Wright; Alan Flores
Journal:  Neurol Clin Pract       Date:  2015-06

Review 7.  Vascular Cognitive Impairment.

Authors:  Jonathan Graff-Radford
Journal:  Continuum (Minneap Minn)       Date:  2019-02

8.  Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study.

Authors:  Santiago Palacio; Leslie A McClure; Oscar R Benavente; Carlos Bazan; Pablo Pergola; Robert G Hart
Journal:  Stroke       Date:  2014-07-17       Impact factor: 7.914

9.  The relevance of living supports on antiplatelet adherence and trial participation: the SPS3 trial.

Authors:  Brandy L Lewis; Lesly A Pearce; Thalia S Field; Carole L White; Oscar R Benavente
Journal:  Int J Stroke       Date:  2014-03-24       Impact factor: 5.266

10.  Functional health and white matter hyperintensities as effect modifiers of blood pressure-lowering on cognitive function and vascular events in older Secondary Prevention of Small Subcortical Strokes trial participants.

Authors:  Manuel R Blum; Rebecca Scherzer; Jesse C Ikeme; Oscar R Benavente; Leslie A McClure; Carmen A Peralta; Michelle C Odden
Journal:  J Hypertens       Date:  2020-08       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.